The University of Tennessee Health Science Center’s (UTHSC) Junling Wang, PhD, professor in the Department of Clinical Pharmacy and Translational Science, has been awarded over $1.4 million from the National Institutes of Health (NIH) to further her research on the equity and economic effects of medication management therapy programs. Her project titled, “Equity and Economic Effects… Read More
Ramesh Narayanan, PhD, associate professor in the Department of Medicine-Hematology and adjunct associate professor in the Departments of Urology and Pharmaceutical Sciences at the University of Tennessee Health Science Center (UTHSC), has been awarded over $2 million from the National Institutes of Health (NIH) to develop novel tools and next generation drugs designed to treat… Read More
Glaucoma is the leading cause of irreversible blindness in the world and affects more than three million people in the United States each year. Currently, there is no cure for this crippling disease, only the option to treat one’s symptoms. Monica M. Jablonski, PhD, professor in the Department of Ophthalmology in the College of Medicine… Read More
Helena Parfenova, PhD, professor of Physiology in the College of Medicine at the University of Tennessee Health Science Center (UTHSC), was recently awarded $2.1 million to further study the functions and mechanisms behind neonatal seizures, and to potentially uncover naturally-occurring defensive mechanisms to prevent cerebrovascular disease in newborns. The neonatal brain is vulnerable to compromises… Read More
Large artery strokes, a form of ischemic stroke, are the most dangerous form of stroke. About 30 percent of the stroke cases seen in Memphis are classified as large artery acute ischemic stroke, and the way patients are positioned during the immediate ‘hyperacute’ hours after they experience this severe type of stroke could impact the… Read More
